Pharmaceutical Technology

MAY 22, 2023

The Covid-19 pandemic saw a proliferation in novel vaccine technologies being produced rapidly. With the emergence of vaccines came accusations of technology encroachment amongst biotech companies. CureVac’s lawsuits add to a complex legal landscape for Pfizer/BioNTech that already includes ones from Moderna.

Vaccines 116

Vaccines Communication 116

Pharmaceutical Technology

SEPTEMBER 29, 2022

The mRNA-1273.222 vaccine comprises 25µg doses of mRNA-1273 (Spikevax) and a vaccine candidate against the BA.4/BA.5 Moderna has so far obtained authorisations for Omicron-targeting bivalent booster vaccine in the US, Canada, Europe, Australia, South Korea, Switzerland, Japan, Singapore, Taiwan and the UK.

Vaccines 59

Vaccines 59

pharmaphorum

JUNE 6, 2022

With vaccine hesitancy leading to a rise in measles cases, the FDA’s approval of GlaxoSmithKline’s venerable vaccine Priorix for sale in the US looks timely. The post FDA clears GSK’s Priorix, first new MMR vaccine in 50 years appeared first on. Photo credit: CDC/Dr Heinz F Eichenwald via Wikipedia.

Vaccines 59

Vaccines 59

Express Pharma

OCTOBER 12, 2023

At the 2023 Grand Challenges Annual Meeting, Bill Gates, Co-chair of the Bill & Melinda Gates Foundation, announced new investments to advance access to mRNA research and vaccine manufacturing technology that will support low- and middle-income countries’ (LMICs) capacity to develop high-quality, lifesaving vaccines at scale.

Vaccines 52

Vaccines 52

Pharmaceutical Technology

FEBRUARY 3, 2023

Only a few weeks into the new year, the prospect of getting a successful advanced HIV vaccine shrank after the discontinuation of yet another late-stage trial. On January 18, Janssen, a Johnson & Johnson (J&J) subsidiary, stated that its vaccine was not effective in preventing HIV infections.

Vaccines 117

Vaccines Immunity Immunization 117

Pharmaceutical Technology

MAY 11, 2023

Results published in Nature for a personalised pancreatic cancer vaccine that uses neoantigens from patients’ tumours have lent further support to early positive signals. The vaccine, developed by BioNTech, led to half of the patients with pancreatic cancer in the Phase I trial remaining cancer-free 18 months later.

Vaccines 138

Vaccines Immunity Immunization 138

pharmaphorum

OCTOBER 7, 2021

The WHO has given a green light to widespread use of GlaxoSmithKline’s malaria vaccine in Africa, in what could be a major turning point in the fight against the disease. The vaccine could soon be available – as an additional malaria control tool – to more children across Africa. link] #VaccinesWork.

Vaccines 98

Vaccines Hospitals 98

European Pharmaceutical Review

DECEMBER 19, 2023

Many of today’s vaccines are produced in ready-to-inject liquid formulations that must be kept cold to maintain stability. However, this greatly complicates both the worldwide distribution and stockpiling of vaccines and other drugs. A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient.

Vaccines 111

Vaccines Communication Immunity Immunization 111

pharmaphorum

DECEMBER 14, 2022

The mRNA technology that was deployed so effectively in vaccines against COVID-19 has now been found to offer similar promise against cancer, according to Merck & Co and Moderna. The vaccine primes the immune system to attack the tumour cells, while Keytruda blocks an immunological ‘brake’ that protects the cancer.

Vaccines 98

Vaccines Immunity Immunization 98

pharmaphorum

JULY 30, 2021

Takeda has decided development of its norovirus vaccine candidate outside Japan will be more efficient if it is spun out into a dedicated company. In 2016, the drugmaker spun out a 25-strong team of UK researchers – focused on neurological and psychiatric disorders – into a new company called Cerevance.

Vaccines 52

Vaccines 52

pharmaphorum

FEBRUARY 19, 2021

A global emergency stockpile of Ebola vaccine is being deployed to curb the epidemic, although experts are confident that synergies in public health practises will ensure a rapid response to both. During the 2014-2016 Ebola outbreak, Guinea was one of the worst impacted countries and saw more than 2,543 deaths. “Our

Vaccines 64

Vaccines 64

European Pharmaceutical Review

APRIL 26, 2023

Built to deliver Moderna’s ten-year strategic partnership with the UK government, announced in March 2023, the MITC will incorporate research, development and a manufacturing facility for mRNA vaccines. Its Health Tech cluster has grown to over 70 life science organisations since its launch in 2016. Credit: Tom Weller Photography. (L-R)

Vaccines 52

Vaccines 52

pharmaphorum

MAY 26, 2021

The government’s last attempt to shake up patient data-sharing – 2013’s Care.data scheme – suffered from a number of false starts and was eventually shut down in 2016. Its demise came after the Caldicott review into safeguards found issues with consent and opt-out processes.

Communication 116

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 116

PharmaShots

MAY 23, 2023

Stock Exchange: TYO With focus areas extending to the discovery and development of biopharma products, AnGes is dedicated to developing genetic medicines and therapeutic vaccines for intractable or rare diseases. Approved Cell and Gene Therapy: Collategene Founded Year: 1999 Total Employees: ~140 Headquarters: Osaka, Japan Market Cap: $162.8M

Diabetes 58

Diabetes Immunity Immunization Pharmaceutical Companies 58

Pharmaceutical Technology

SEPTEMBER 5, 2022

Following AstraZeneca’s success in vaccine development during the Covid-19 pandemic , the pharmaceutical giant is now looking to expand its scope through acquisitions across a range of indications, says CEO Pascal Soriot. “We Between 1 May 2016 and 31 May 2021, the FDA approved 207 drugs for cancer and malignant haematology.

Vaccines 114

Vaccines 114

pharmaphorum

FEBRUARY 23, 2022

The global health crisis caused spending on healthcare to increase , due to the funding provided to the development and purchases of vaccines and treatments, as well as support provided for the associated infrastructure. billion in 2020.

Biosimilars 98

Biosimilars Vaccines 98

pharmaphorum

JANUARY 29, 2023

Think about recent technological breakthroughs such as mRNA vaccines and the potential for mRNA-based therapeutics, or the recent ramp up in vaccine production facilities – to name just a few examples. Attracted by healthcare’s steady and rising revenues, financial investors made 55% of 2022’s acquisitions, up from 43% in 2016.

Nursing Homes 98

Nursing Homes Hospitals Vaccines 98

pharmaphorum

APRIL 11, 2022

Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. At Janssen, we strive to improve access to our innovative medicines and vaccines and achieve the best possible outcomes for patients across the world.

Pharmaceutical Companies 115

Pharmaceutical Companies Pharmaceutical Companies Vaccines Packaging 115

European Pharmaceutical Review

JULY 20, 2022

Our research looked at products that were voluntarily withdrawn, or had their licence revoked or suspended within the EU for a safety reason between 2012 and 2016. Researchers also study the long-term effects of medicines and vaccines, as well as the safety of new and advanced products. Study focus. almitrine – a respiratory stimulant.

Adverse Reactions 97

Adverse Reactions Diabetes Hospitals Vaccines 97

pharmaphorum

SEPTEMBER 27, 2021

As the vaccines were developed and rolled out, the disparity in their take up among different sections of the community highlighted how excluded some minority communities felt from areas of healthcare. Vaccine hesitancy was the most recent and highest profile example of distrust among minority groups towards the pharmaceutical industry.

Vaccines 122

Vaccines Communication Drug Development 122

pharmaphorum

SEPTEMBER 18, 2020

All eyes may be on Moderna’s COVID-19 vaccine at the moment, but the US biotech hasn’t been idle in business development elsewhere, signing back-to-back deals with Vertex and Chiesi that have brought in $100 million upfront. .

Vaccines 105

Vaccines 105

Pharmaceutical Technology

JUNE 27, 2022

As part of the symposium, Dr Graham Foster, who was appointed National Clinical Chair for the Hepatitis C Delivery Network in January 2016, shed light on hepatitis C care strategies in England. She says this could involve using family health care facilities where children also receive their vaccines.

Vaccines 105

Vaccines 105

Express Pharma

DECEMBER 11, 2023

The COVID-19 pandemic also highlighted the vital role of the cold chain in ensuring patient safety during vaccine distribution. And, with India’s vaccine, biopharma, and clinical trials market projected to grow in double-digits, there will be an increasing demand for efficient cold chain facilities. billion in 2022.

Packaging 115

Packaging Vaccines 115

Putting Patients First Blog

APRIL 30, 2024

Assessment of length and readability of informed consent documents for COVID-19 vaccine trials. Rutta Chief Executive Officer i Emanuel, E. and Boyle, C. JAMA Network Open, 4(4). doi:10.1001/jamanetworkopen.2021.10843 2021.10843 ii Krishnamurti, T. and Argo, N. Medical Decision Making, 36(6), 726-740. McLellan, L., Bedarida, G., Emanuel, E.,

Documentation 52

Documentation Communication Mayo Clinic Drug Development 52

FDA Law Blog: Biosimilars

FEBRUARY 4, 2025

2014) June 2016 Vaxchora (Pax Vax Bermuda) Cholera vaccine for travelers $ 290 (June 2016) Aug 2017 Benznidazole (Chemo Research) Chagas disease UNK June 2018 Moxidectin (Medicines Devt for Global Health) Onchocerciasis, or river blindness UNK (May 2019) July 2018 Krintafel (GSK) P.

Vaccines 52

Vaccines 52

RX Note

FEBRUARY 4, 2024

Additionally, pharmacists in many countries, including the United States, UK and Australia, are empowered to administer vaccines, improving accessibility and reducing healthcare system strain. Most community pharmacies routinely provide preventive services like blood pressure, glucose and lipid screenings.

Community Pharmacies 52

Community Pharmacies Medical Records Compounding Diabetes 52

pharmaphorum

SEPTEMBER 18, 2020

In June 2007, AstraZeneca completed the acquisition of vaccine maker MedImmune, buying its drug-development pipeline for $15.2 This resulted in AstraZeneca becoming possibly the most talked-about pharma company in the world when its own vaccine emerged as the frontrunning candidate. Pfizer makes its move.

Vaccines 116

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 116

European Pharmaceutical Review

FEBRUARY 3, 2023

Compared to other leading EU countries (Italy, Spain, Germany, France), the UK has experienced the largest decline in its global share of new medicine launches between 2016-2021. The ABPI emphasised that recent Government policy has led to disinvestment in medicines through the cap on growth for a decade.

Vaccines 59

Vaccines 59

FDA Law Blog: Biosimilars

APRIL 7, 2025

Zenrelia comes with serious warnings, including a boxed warning against the use of Zenrelia during vaccination. CVM also objected to the truncation of other information about the timing of vaccines in these promotional materials. Zenrelia promotional materials also included claims about clinical data that the Agency found actionable.

Vaccines 64

Vaccines Adverse Reactions 64

Pharmaceutical Business Review

OCTOBER 13, 2023

In 2016, AGC Biologics purchased the Heidelberg campus that provides full-scale support for starting material for in-vitro transcription mRNA vaccines​ as well as raw material for adeno-associated vectors and lentiviral vectors. The campus has become the company’s European Center of Excellence for plasmid DNA.

Vaccines 52

Vaccines 52

pharmaphorum

JANUARY 21, 2022

And as with many healthcare challenges, it is an issue that has been brought into sharp focus by COVID-19, during which we have seen huge investments in ground-breaking vaccines, quickly followed by inequities in access. By 2016, Gilead already had competition for the HCV market, when MSD launched their product at €47,000 per treatment.

Vaccines 52

Vaccines 52

Eye on FDA

JANUARY 12, 2022

And while the imprint of the communications style of a new commissioner is something that might be anticipated, we are getting a commissioner who we had once before in 2016-2017, a period where the quantity of communications was not robust. When will the products be fully approved?

Communication 73

Communication Vaccines 73

pharmaphorum

SEPTEMBER 22, 2021

Texas-based Abexxa has been on the Boehringer’s radar since it was set up, as it provided seed funding for the preclinical-stage company in 2016, buying into its approach of developing antibodies against targets inside cancer cells, rather than on the cell membrane. Last December, Boehringer paid €1.8

Vaccines 92

Vaccines Immunity Immunization 92

Putting Patients First Blog

JULY 22, 2024

This includes wholesalers, payers, and other entities involved in pricing and distribution, all of which significantly influence the availability and cost of medical products, including drugs, biologics, vaccines, and devices. Although these considerations extend beyond the current RFI, the NHC believes they warrant attention. Pistollato, M.,

Documentation 52

Documentation Vaccines 52

Pharmaceutical Technology

JUNE 30, 2022

In Muratov’s opinion, this was reflective of a wider pattern seen in almost any other field of research, which could now change with the development of Covid-19 vaccines and antivirals. Acoziborole was previously discovered by the company Anacor Pharmaceuticals, which Pfizer acquired in 2016. Covid-19 had other knock-on effects.

Vaccines 64

Vaccines Hospitals 64

pharmaphorum

JANUARY 9, 2023

1 Kenya, for example, entered the pandemic with no human vaccines manufacturing facility and established the BioVax institute for local vaccine manufacture with a major plant investment starting in 2023. Research and development spend by major companies has increased 44% since 2016.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 98

pharmaphorum

APRIL 21, 2022

Overall spending on medicines rose 12% in 2021 to $407 billion, driven by a $29 billion spend on COVID-19 vaccines and medicines. Prescription drug use in the US soared last year, as might be expected during a pandemic, but is expected to fall back sharply in 2023, according to IQVIA’s latest report on the sector.

Vaccines 52

Vaccines Biosimilars 52